Advanced Biomed Inc. (NASDAQ:ADVB) Short Interest Down 34.7% in August

Advanced Biomed Inc. (NASDAQ:ADVB) was the target of a significant drop in short interest in the month of August. As of August 14th, there was short interest totaling 37,364 shares, a drop of 34.7% from the July 30th total of 57,213 shares. Based on an average daily volume of 231,612 shares, the short-interest ratio is currently 0.2 days. Currently, 3.1% of the shares of the company are sold short.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on ADVB. Weiss Ratings raised Advanced Biomed from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, July 23rd. Wall Street Zen upgraded Advanced Biomed to a “hold” rating in a research note on Saturday, August 22nd. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has an average rating of “Sell”.

Advanced Biomed Stock Performance

Advanced Biomed stock opened at $9.77 on Thursday. Advanced Biomed has a fifty-two week low of $3.61 and a fifty-two week high of $24.23. The firm’s 50-day simple moving average is $7.97 and its 200 day simple moving average is $5.92. The stock has a market cap of $16.12 million, a PE ratio of 2.03 and a beta of -0.29.

Advanced Biomed Company Profile

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.